57.59 USD
↗ 1.31 (2.33%)LIVE (AS OF 12:07 PM EDT)
Xenon Pharmaceuticals Inc
XENENASDAQ • USD
Market: OPEN
Xenon Pharmaceuticals Inc (XENE) is currently trading at $57.59. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, XENE trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Sep 15, 2026.
Open?$56.67
High?$57.78
Low?$56.27
Prev. Close?$56.28
Volume?241.5K
Avg. Volume?632.8K
VWAP?$57.31
Rel. Volume?0.38x
Bid / Ask
Bid?$57.34 × 300
Ask?$57.50 × 100
Spread?$0.16
Midpoint?$57.42
Valuation & Ratios
Market Cap?5.5B
Shares Out?96.7M
Float?90.8M
Float %?93.9%
P/E Ratio?N/A
P/B Ratio?4.39
EPS?-$4.23
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Employees
370
Market Cap
5.5B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-11-05
Address
200 - 3650 GILMORE WAY
BURNABY,
Phone: (604) 484-3300
BURNABY,
Phone: (604) 484-3300
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?38
Piotroski F-Score?0/9Weak
Altman Z-Score?59.40Safe
Confidence?52%Low
Short InterestHigh
Short % of Float?6.99%Elevated
Short Interest?6.3M
Days to Cover?9.1
Free Float90.8M
Avg Daily Volume698.3K
Settlement Date2026-08-31
Financial Health
Current Ratio?21.02Strong
Quick Ratio?21.02Strong
Cash Ratio?2.66Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?4.39FAIR▾
Peers100
S&P41
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-12.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-32.9%WEAK▾
S&P6
ROA?-31.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-338527000
Enterprise Value?$5.3B
Fundamentals ratios updated end of day